Home › Funds › Stonebridge Wealth Management, LLC › ABT

Stonebridge Wealth Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Stonebridge Wealth Management, LLC reported holding 7,222 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$714K, representing 0.64% of its reported portfolio and ranking #24 among its reported holdings. Stonebridge Wealth Management, LLC has disclosed ABT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)7.22K sh
Reported value held$713.74K
Portfolio Weight0.64%
First reportedQ2 2025
Last changeHold
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Stonebridge Wealth Management, LLC's ABT position evolved

Stonebridge Wealth Management, LLC first disclosed a stake in ABT in Q2 2025 at 7,222 shares (US$982K). Across 6 filings, Stonebridge Wealth Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 7,222 shares valued at US$714K.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 7.22K $982.21K New
Q3 2025 7.22K $967.27K Hold
Q4 2025 7.22K $904.81K Hold
Q1 2026 7.22K $741.46K Hold
Q2 2026 7.22K $655.31K Hold
Q3 2026 7.22K $713.74K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Stonebridge Wealth Management, LLC held ABT?

Stonebridge Wealth Management, LLC has disclosed ABT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Stonebridge Wealth Management, LLC's current position in ABT?

As of Q3 2026, Stonebridge Wealth Management, LLC holds 7.22K shares of ABT (ABBOTT LABORATORIES), valued at $713.74K, representing 0.64% of its reported portfolio and ranking #24.

Has Stonebridge Wealth Management, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Stonebridge Wealth Management, LLC held unchanged its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.